Wahl Bryan (CIK 1841401) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-19). Recent activity: Sell TARS (4,084 shares), Sell TARS (4,125 shares), Sell TARS (4,231 shares), Buy TARS (24,236 shares), Sell TARS (3,341 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-19 | Tarsus Pharmaceuticals, Inc. (TARS) | General Counsel | Sell | 4,084 | $283,511 |
| 2026-03-19 | Tarsus Pharmaceuticals, Inc. (TARS) | General Counsel | Sell | 4,125 | $283,429 |
| 2026-03-19 | Tarsus Pharmaceuticals, Inc. (TARS) | General Counsel | Sell | 4,231 | $283,477 |
| 2026-03-17 | Tarsus Pharmaceuticals, Inc. (TARS) | General Counsel | Buy | 24,236 | $0 |
| 2025-03-20 | Tarsus Pharmaceuticals, Inc. (TARS) | General Counsel | Sell | 3,341 | $154,655 |
| 2025-03-20 | Tarsus Pharmaceuticals, Inc. (TARS) | General Counsel | Sell | 3,261 | $154,571 |
| 2025-03-20 | Tarsus Pharmaceuticals, Inc. (TARS) | General Counsel | Sell | 3,084 | $154,539 |
| 2025-03-18 | Tarsus Pharmaceuticals, Inc. (TARS) | General Counsel | Buy | 19,213 | $0 |
Source: SEC Form 4 filings · as of 2026-03-19